ORCL Insider Buying & Government Contracts (2026)

ORCL insider buying and selling over the past year

Insiders at ORACLE CORP only sold stock in the open market over the past year: 10 Form 4 sales totaling $45.35M, against no open-market purchases.

Only 1 of the 10 sales were flagged as Rule 10b5-1 plan trades, so most selling was discretionary rather than pre-scheduled. Activity clustered in 2025-10 (3 trades) and 2025-12 (3 trades); the latest filing in this window is dated 2026-09-22. The average open-market sale price was $230.45; the last close of $128.23 is 44.4% below that level, so sellers exited above the current price. The single largest trade was a sale of 49,365 shares worth $13.97M on 2025-10-28. Since the most recent filing the stock has moved -14.1%, from $149.20.

Where ORCL trades relative to its one-year range

ORACLE CORP closed at $128.23 on 2026-10-16, inside a one-year range of $114.99 to $291.31. That puts the stock near the bottom of its range, at 7.5% of the distance from low to high. Over one year the share price moved -59.0%, and over roughly three months +1.4%. Average daily volume over the last month was about 30,828,740 shares.

Across 209 companies in the same SEC industry group (SIC 73) with a full year of prices in Gemral Edge, the median one-year return was -10.2%. ORCL is behind that median and beat 5% of that peer group on this measure.

Members of Congress who traded ORCL

STOCK Act disclosures show 85 trades in ORCL by 22 members of Congress over five years (46 purchases, 39 sales), most recently on 2026-09-25. The most active traders were Ro Khanna (D-CA), 24 trades; Josh Gottheimer (D-NJ), 7 trades; Gilbert Ray Cisneros, Jr. (D-CA), 6 trades; Jared Moskowitz (D-FL), 5 trades; Jefferson Shreve (R-IN), 5 trades.

By party the trades split 55 by Democrats, 30 by Republicans; by chamber, 79 from the House, 6 from the Senate.

ORACLE CORP federal contract exposure

Federal procurement records resolve 6 prime award actions to ORACLE CORP, worth $1.13B across 1 agencies. Department of Veterans Affairs accounts for 100.0% of that value ($1.13B), so revenue from this channel depends heavily on one buyer.

ORCL lobbying disclosures

ORACLE CORP appears in 342 Lobbying Disclosure Act filings between 2018 and 2026, with $54.09M in reported lobbying spend.

Compare ORCL with indexed peers from the same industry group

These peers have full Gemral Edge dossiers and the closest one-year price move to ORCL:

• FISV one-year return -59.7%
• CRWV one-year return -56.7%
• CSGP one-year return -56.5%
• APP one-year return -56.1%
• FICO one-year return -52.4%

Sources and method

Every figure above is computed from public filings stored in Gemral Edge, not estimated. Insider figures count only open-market purchases and sales reported on SEC Form 4; option exercises, grants and gifts are excluded because they do not reflect a decision to buy or sell at market prices.

• SEC EDGAR Form 4 (edge_insider_trades, codes P/S open-market only) — as of 2026-09-22
• edge_prices_eod (end-of-day close) — as of 2026-10-16
• House PTR / Senate eFD disclosures (edge_congress_trades) — as of 2026-09-25
• FPDS / USAspending (edge_contracts, tier-1 resolved) — as of 2026-09-25
• Senate LDA filings (edge_lobbying_filings)

ORCL data questions

Are ORCL insiders buying or selling stock?

Insiders at ORACLE CORP only sold stock in the open market over the past year: 10 Form 4 sales totaling $45.35M, against no open-market purchases.

What is the one-year price range for ORCL?

Based on end-of-day closes through 2026-10-16, ORCL traded between $114.99 and $291.31, last closing at $128.23.

Has any member of Congress traded ORCL stock?

Yes. 22 members disclosed 85 trades in ORCL over five years; the most recent disclosed trade date is 2026-09-25.